IPO | Erytech Pharma S.A. rings the Nasdaq Stock Market Closing Bell
9 November 2018
France | USA | International Capital Markets
Gide advised Erytech Pharma S.A. (Nasdaq: ERYP) on the French law aspects of its IPO on the Nasdaq Global Select Market in November 2017.
Partner Arnaud Duhamel and senior associate Guilhem Richard went to the Nasdaq MarketSite in Times Square, New York, this week. In honour of the event, Gil Beyen, Chairman and Chief Executive Officer, rang the Closing Bell.
Warm thanks also go to associates Juliette Pierre and Mariléna Gryparis for their work on the IPO alongside Arnaud and Guilhem!